台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    60.0
  • 漲跌
    ▲0.2
  • 漲幅
    +0.33%
  • 成交量
    11
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智基 (6294)籌碼相關-玉山-新莊 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

玉山-新莊 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/20158.80161.0059.500910.00%
2025/01/1400.00159.1059.00-191-1.09%
2025/01/13159.0000.0059.401911.09%
2024/12/2600.00461.2861.10-490-4.43%
2024/12/2400.00162.1062.00-190-1.11%
2024/12/2300.00361.4061.40-390-3.31%
2024/12/20260.6000.0060.802902.20%
2024/12/16261.4500.0062.102902.21%
2024/12/13163.0000.0063.101891.12%
2024/12/11263.9500.0064.002902.22%
2024/12/10165.3000.0065.301911.10%
2024/12/09166.40366.7366.40-294-2.13%
2024/12/0600.00165.9065.90-194-1.05%
2024/12/05265.3000.0065.202952.10%
2024/11/28163.2000.0063.701981.01%
2024/11/27164.7000.0064.701991.01%
2024/11/26165.1000.0065.301991.01%
2024/11/22263.8000.0063.402962.06%
2024/11/20465.3500.0064.404914.38%
2024/11/190.169.8800.0069.300.1880.11%
2024/11/1500.000.472.4072.60-0.4101-0.44%
2024/11/140.271.654.171.8169.70-3.9102-3.82%
2024/11/130.377.83977.5077.40-8.797-8.88%
2024/11/122.386.112.686.0686.00-0.390-0.28%
2024/09/1900.000.296.9096.50-0.2139-0.17%
2024/09/1600.000.197.6096.80-0.1139-0.10%
2024/08/191106.0000.00106.0011300.77%
2024/08/132103.502102.00101.5001090.00%
2024/08/09298.803100.60100.50-193-1.07%
2024/08/07199.5000.00108.001971.02%
2024/08/0200.001100.50100.50-188-1.13%
2024/08/011100.5000.00101.001881.13%
2024/07/2200.001100.50101.00-190-1.10%
2024/07/170.1102.0000.00102.000.1910.11%
2024/07/110.1101.5000.00101.500.1940.11%
2024/07/0400.001102.00102.50-1128-0.78%
2024/06/211100.5000.00100.5011400.71%
2024/06/200101.0000.00101.0001420.01%
2024/06/1400.000.7100.50100.50-0.7148-0.47%
2024/06/1300.001100.50100.50-1152-0.66%
2024/06/121100.5000.00101.0011550.64%
2024/06/111102.0000.00101.5011560.64%
2024/06/071102.5000.00102.5011550.64%
2024/05/290.3103.0000.00102.500.31590.19%
2024/05/241103.0000.00103.0011570.63%
2024/05/220.2104.0000.00103.000.21570.13%
2024/05/211102.5000.00102.0011550.64%
2024/05/201104.0000.00103.5011540.65%
2024/05/161106.0000.00107.0011500.67%
2024/05/150103.5000.00104.0001480.01%
2024/05/134.1107.0000.00107.004.11273.23%
2024/05/0700.001119.50119.50-1119-0.84%
2024/05/0300.000.1118.00118.50-0.1117-0.04%
2024/04/191116.0000.00116.0011130.88%
2024/04/1700.005117.00117.00-5111-4.47%
2024/04/165.1113.0200.00114.005.11114.55%
2024/04/111.2119.0000.00119.501.21011.13%
2024/04/0900.000124.00124.00077-0.01%
2024/03/221123.631123.00122.50060-0.02%
2024/03/1500.001120.50121.50-147-2.12%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音